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Abstract Cerebellar ataxia (hereinafter referred to as
CA) designate a group of neurodegenerative disorders.
CA is distinguished into a group of hereditary and non-
hereditary disorders. CA shows clinically progressive
features and accompanies various neurological abnor-
malities. However, there are very few studies and case
reports in Korean patients. To estimate the prevalence
rate and current status of the CA patients in Korea, we
used data from the Health Insurance Review and
Assessment Service (HIRAS) and from the National
Health Insurance Corporation. To evaluate the functional
status of CA patient in Korea, we conducted a simple
random sampling among the 500 members of Korea
Ataxia Society registered on its homepage. We evaluat-
ed the functional status and degree of disturbance to
their everyday life with modified Rankin scales and
Barthel ADL index. Using the data from HIRAS, we
could estimate the prevalence rate of CA patients in
Korea as 8.29 patients/100,000 persons. The prevalence
rate of hereditary and non-hereditary cerebellar ataxia
was 4.99 patients/100,000 persons and 3.30 patients/
100,000 persons, respectively. Data on rare intractable
diseases reported by the Korean Centers for Disease
Control and Prevention in 2006 suggested that the
number of CA patients who have visited medical
institutes was almost doubled for the 2-year period.
The medical expense and hospital stay also increased
4.5- and 3-fold, respectively. After severity evaluation
with modified Rankin scales and Barthel ADL index,
we found that most CA patients in Korea have ataxia-
related difficulties in their everyday life.
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Introduction
Cerebellar ataxia (hereinafter referred to as CA) designate a
group of neurodegenerative disorders. CA is distinguished
into a group of hereditary and non-hereditary disorders [1,
2]. Hereditary CA can have an autosomal-dominant,
autosomal-recessive, X-linked, or mitochondrial mode of
inheritance [1]. Non-hereditary CA can be symptomatic or
idiopathic, and symptomatic CA may be caused by multiple
causes including malformations, toxic agents, endocrine
disorders, and infections. CA shows clinically progressive
features and accompanies various neurological abnormali-
ties. The symptoms include not only walking difficulty due
to cerebellum degeneration, but also optic atrophy, oph-
thalmoplegia, retinitis pigmentosa, sensory loss, and dysar-
thria [3, 4]. These symptoms cause many difficulties in the
everyday life of CA patients [2]. Although the patients have
a lot of difficulties with their everyday life, CA is such a
rare disease that there have been only few studies and case
reports in Korea [5]. This study aimed to provide useful
data for establishing a more appropriate national policy by
identifying the prevalence rate of CA and examining its
current status in collaboration with Korea Centers for
Disease Control and Prevention, conclusively to increase
the social awareness of CA.
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Sources of Patient Data
There are two main organizations providing national
health insurance in Korea: the National Health Insurance
Corporation (NHIC) and the Health Insurance Review
and Assessment Service (HIRAS). NHIC is the organi-
zation which provides health care benefits in cases of
illness and injuries, to enhance public health and
strengthen social security. Data from NHIC were
derived from the payment request sheet generated from
each visit to hospitals and both inpatient or outpatient
clinics. NHIC covers most Korean citizens and regis-
tered residents of foreign nationality, except special
population groups, such as foreign military personnel.
It encompasses all hospital visits nationwide. HIRAS is
the organization which reviews whether the medical
service fee was fairly charged in accordance with the
law, to maintain the quality standard, as well as an
adequate level of medical fees. Data from HIRAS also
covers all hospital visits nationwide.
Prevalence Rate Survey
To estimate the prevalence rate of CA patients in Korea, our
research team used data from the HIRAS. First, we selected
the patients who were candidates for the health insurance
and medical care review and assessment, from 1 January
2008 to the end of December 2008, using data from
HIRAS. Then, we sampled those whose principal and
secondary diagnosis codes were registered as G11 in the
International Classification of Disease-10 (hereinafter ICD-
10; Table 1). Ataxia is not a main symptom in hereditary
spastic paraplegia (G11.4); therefore, those patients were
excluded from our database. Then patients were classified
across year, and overlapping data was also removed, based
on the serial number. In cases when the major and minor
diagnosis codes differed, the major diagnosis code was set
as the main criterion. Thus, the patients were reclassified
according to the sub-diagnosis codes within G11 and we
established a database of presumed CA patients in Korea,
according to the G11 diagnosis code and based on
information gathered by HIRAS between 2006 and 2008.
We classified the patients registered as G11.0, G11.1,
G11.3, G11.8, and G11.9 as hereditary CA and those
diagnosed with G11.2 as non-hereditary cerebellar ataxia,
and estimated the prevalence rate in each group, as
presented in Fig. 1.
Health Care Status Survey in CA Patients in Korea
To examine the current health care status of the CA
patients in Korea, we used data from the NHIC. We
sampled the patients, whose diagnosis codes corre-
sponded to G11 of ICD-10 from the data registered at
NHIC as of December, 2008. Then, the patients
registered as G11.4 were excluded from estimating the
prevalence rate, as described above.
For each group, we examined the annual medical
expense per capita, hospital stay per capita, distribution of
medical care, and registration as a disabled person.
The Functional Status Evaluation of CA Patients
In this study, we originally designed the functional status
evaluation of the CA patients as follows: First, we
planned a simple random sampling of the database and
follow-up study using the medical records. We also
planned telephone interview or visiting survey to evaluate
the severity in cases when the medical records were
insufficient or unavailable. However, it was impossible to
identify individual patients through the data from HIRAS
due to the “Law of Private Information Protection in
Public Institutions”. Therefore, to evaluate the severity,
we conducted a simple random sampling among the 500
members of Korea Ataxia Society registered on its
homepage. Following this process, we conducted tele-
phone interviews or home visits to administer the
modified Rankin scales and Barthel ADL index in order
to evaluate the severity of CA and the degree of
disturbance to the patients’ everyday life.
Table 1 Comparison on the using rate of medical service in cerebellar ataxia patients
Number Medical expense: Korean won (US dollar: USD) Hospital visiting days
2008 Hereditary 1,243 1,181,139 won (about 984.3USD) 13.9
Non-hereditary 943 1,544,979 won (about 1,287.5 USD) 17.7
Total 2,186 2,726,118 won (about 2,271.8 USD) 31.6
2006 Total 1,450 595,189 won (about 496.0 USD) 10.2
Hereditary cerebellar ataxia with hereditary, Non-hereditary cerebellar ataxia without hereditary, Medical expense (Korean won), medical expense
per capital, Hospital visiting days hospital visiting days per capital
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Results
Prevalence of CA in Korea
According to data from HIRAS, the number of patients
estimated to have CA in Korea was 3,996. To estimate the
prevalence rate of CA, we used the entire number of people
who applied to HIRAS in 2008 (i.e., 48,606,000 persons)
as the study population and estimated the prevalence rate of
CA patients in Korea as 8.22 patients/100,000 persons.
When the 3,996 CA patients were classified according to
the sub-diagnosis code G11, the non-hereditary CA patients
were 1,594 (39.9% of the entire CA patients) and hereditary
CA patients were 2,402 (60.1%). Thus, we estimated the
prevalence rate of hereditary CA patients as 4.94 patients/
100,000 persons and non-hereditary CA patients as 3.27
patients/100,000 persons, respectively.
With respect to the gender ratio for the hereditary and the
non-hereditary CA groups, there were 1,279 men (53.2%)
and 1,123 women (46.8%) in the hereditary CA group,
whereas there were 908 men (57.0%) and 686 women
(43.0%) in the non-hereditary group. These findings show
that male patients are more frequently observed than
women in both groups.
With respect to the age-specific prevalence rate, as
presented in Fig. 1, there were 226 patients of age 0–
9 years, 149 of age 11–19 years, 202 of age 20–29 years,
272 of age 30–39 years in the hereditary CA group, which
suggested that 849 (35.3%) out of total 2,402 were
diagnosed under the age of 40. In contrast, non-hereditary
CA was mainly diagnosed over the age of 30, with 463
patients of age 50–59 years, 534 of age 60–69 years, and
363 of age 70 years and above. Of the 1,549 patients, 1,360
(85.3%) were aged 50 or above, as presented in Fig. 2.
Fig. 1 The flowchart about building of the database with the data from Health Insurance Review and Assessment Service. CA cerebellar ataxia)
Fig. 2 Comparison of numbers
according to age between





Cerebellum (2012) 11:733–738 735
Health Care Status Survey in CA Patients in Korea
We were able to identify the number of CA patients, the
annual medical expense per capita and the annual hospital stay
per capita, as of December 2008. Comparing these results to
the reports on rare intractable diseases published by the Korea
Center for Disease Control and Prevention in 2006, it showed
that the number of CA patients who have visited medical
institutes was almost doubled for the 2-year period. The
medical expense per patient increased 4.5-fold, from 595,189
Korean won (about 496.00 U.S. dollars, USD) to 2,726,118
Korean won (about 2,271.8 USD), and the hospital stay also
increased 3.1-fold, as shown in Table 1.
The Functional Status Evaluation of CA Patients
To evaluate the severity of CA, we randomly sampled the
500 members of Korea Ataxia Society and assigned them to
two study groups, i.e., hereditary and non-hereditary CA,
with 34 sample size for each group. With respect to the
gender ratio for each group, there were 19 men and 15
women in each group. The age distribution for the
hereditary CA group is presented in Table 2.
All patients were surveyed with the modified Rankin
scale via telephone interviews or home visits to evaluate the
severity of CA.
Our results showed that 55.9% of the hereditary CA
patients reported grade 0, 1, or 2 symptoms, but no major
disabilities, so they were able to achieve ordinary self-care.
There were 11.7% with grade 3 who had moderate
disabilities and needed some assistance, but could walk
without assistance; 14.7% with grades 4 and 5 had severe
disabilities and were in bedridden state.
In contrast, there were 64.7% of non-hereditary CA
patients with grade 4 or 5 symptoms who had severe
disabilities, could not walk without assistance, and required
assistance for all basic physical needs. These results suggest
that more than 60% of non-hereditary CA patients show
severe or above level of disabilities (Table 3).
To assess the ability to perform everyday life activities in
each group, the Barthel ADL index was administered via
telephone interview or home visits. The results showed that
58.5% of hereditary CA patients scored 17–20 on the
Barthel ADL index and had only minor difficulties with
everyday life activities; only 17.6% had severe difficulties
and scored 4 or below.
In contrast, in the non-hereditary CA group, 29.4% had
minor difficulties with everyday life activities (score 17–
20), and up to 49.9% showed severe or above level of
disabilities, as presented in Table 4.
Discussion
In Korea, there is a lack of objective studies on the
prevalence rate of CA patients, current status of medical
service use, registration as a disabled person, and severity
evaluation. This was an extensive and objective study with
significant results, using national data from both HIRAS
and NHIC. We established our database according to the
diagnosis code registered in the national statistical data.
Thus, ataxia related to diseases other than CA, such as
Parkinson’s disease, hydrocephalus, myelopathy, and pe-
ripheral nerve disease, could be included, if the symptoms
were registered as ataxia-related diagnosis code in the
Table 2 Distribution of age in a sample was selected from the 500
cerebellar ataxia patients in Korea Ataxia Society through the random
sampling method




<20 4 12 0 0
30–39 9 26 3 9
40–49 12 35 2 6
50≤ 9 26 29 85
Hereditary cerebellar ataxia with hereditary, Non-hereditary cerebellar
ataxia without hereditary
Table 3 The functional status evaluation with Modified Rankins
scales in Cerebellar ataxia patients
Grade Hereditary (%) Non-hereditary (%)
Mild (0, 1, 2) 19 (55.9%) 10 (29.4%)
Moderate (3) 4 (11.8%) 2 (5.9%)
Severe (4, 5) 11 (32.3%) 22 (64.7%)
Total 34 (100%) 34 (100%)
Hereditary cerebellar ataxia with hereditary, Non-hereditary cerebellar
ataxia without hereditary
P value 0.012
Table 4 The functional status evaluation with Barthel index in
Cerebellar ataxia patients
Grade Hereditary (%) Non-hereditary (%)
0–4 (severe) 6 (17.6%) 10 (29.4%)
5–16 (moderate) 8 (23.6%) 14 (41.2%)
17–20 (mild) 20 (58.8%) 10 (29.4%)
Total 34 (100%) 34 (100%)
Hereditary cerebellar ataxia with hereditary, Non-hereditary cerebellar
ataxia without hereditary
P value 0.034
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medical record. Conversely, current CA patients could be
excluded if the ataxia-related diagnosis code was not
entered. Therefore, we cannot rule out the possibility that
some of the data used in this study may be under/
overestimated or less accurate.
Studies about the prevalence rate in all CA patients,
including hereditary and non-hereditary CA, are very rare.
Several nationwide surveys have been performed in Japan
[6–7]. In 2008, the prevalence rate of CA in Japan was
18.5/100,000 [6]. Similarly, a study about the prevalence
rate of CA was conducted in the Hokuriku district in Japan,
from 2005 to 2006, and CA prevalence in that district was
31.1/100,000 [7]. In our study, the overall prevalence rate
of CA in Korea was 8.29 per 100,000, which was lower
compared to results in Japan. This difference might be
attributable to regional and study method differences.
Studies about the prevalence rate and the dominant
subtype of hereditary CA have been conducted in many
countries [8–12]. In many studies, the prevalence rate of
autosomal dominant cerebellar ataxia (ADCA) was 1–4/
100,000 [8–12]. In our study, hereditary CA compromised
60.1% of all CA cases, and the proportion suggested that
the prevalence rate of hereditary CA patients was about
4.98/100,000, which is a little higher than those reported in
other West and Asian countries, but lower than the
prevalence of hereditary CA in Japan.
Several Asian countries also reported the dominant
subtype of ADCA [1, 13–16]. Spinocerebellar ataxia type
3 (SCA3) was the commonest subtype worldwide [17]. The
frequency of SCA3 was higher than that of other subtypes
of ADCA in China, Singapore, and Japan [6, 13–15].
Several frequency studies according to ADCA subtype
were conducted in Korea [18–21]. In one study, the most
frequent subtype was SCA3, followed by SCA2 [21].
However, most studies reported that SCA2 was the most
frequent ADCA [18–20]. Those studies showed that in
Korea, the subtype frequencies of SCA are different from
those in neighboring countries.
The survey on the current status of medical service used
by CA patients showed that the number of patients
increased by as much as 50%, compared to the prevalence
rate survey report of rare and intractable diseases in 2006,
and the medical expense and hospital stay per patient
increased 4.5- and 3-fold, respectively.
The severity evaluation study through random sampling was
conducted with a specific sample, which may not be
representative for the entire population. In addition, the
possibility of selection error in constructing the sample cannot
be ruled out. However, considering the very lowCA prevalence
rate, it can be assumed that the severity evaluation results with
the random sample may have significant implications.
In the severity evaluation study, we found 55.9%
hereditary CA patients who scored gradse 0, 1, and 2 on
the modified Rankin scale, whereas those who scored 17 to
20 on the Barthel index were 58.8%. These results showed
that more hereditary CA patients had minor disabilities. In
contrast, in the non-hereditary CA group, there were 64.7%
patients with grade 4 or below who were not able to walk
without assistance and 64.7% had severe or above level of
disability scoring less than 12 on the Barthel Index. These
results may be attributed to the fact that the number of older
patients was increased in the non-hereditary CA, compared
to hereditary CA, which in turn may lead to more severe
disability level.
Conclusion
This study is the first report on the prevalence rate and
current status of CA in Korea using national statistical data.
It is expected that the social awareness of CA patients
would increase, leading to improvement in the relevant
systems in the future.
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